52m
HotCopper on MSNOpthea's Phase 3 trial results fail to help patients, future of company at riskIt mightn’t be too surprising Opthea (ASX:OPT) applied for a voluntary suspension last week ahead of Monday’s Phase 3 trial ...
Two of the first patients of adaptive Deep Brain Sitimulation (aDBS) Parkinson’s therapy and the neurologist who developed the care system share how life changes and how it doesn’t ...
Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced the successful completion of the Phase III clinical study ...
1h
Stockhead on MSNHealth Check: Opthea’s solvency in question after monumental phase III eye disease trial failureOne of two of Opthea's phase III trials for a common eye disease has failed to meet its primary endpoints, ... Read More The ...
Amy Schumer admitted she was using a new weight loss medication and praised the many benefits of Mounjaro after difficult time using Ozempic years ago.
FDA general secretary Dave Penman said a 10% cut in the entire salary bill of the Civil Service could mean up to 50,000 jobs ...
FAISALABAD: On the direction of Director General Faisalabad Development Authority (FDA) Muhammad Asif Chaudhry, Additional ...
AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical ...
The Food and Drug Administration (FDA) issued the Class II recall of pouches of shredded cheese sold at ALDI's in four states ...
A new wave of menopause advocates, from journalists to founders, is pushing for change—challenging stigma and reshaping the ...
I don't sugarcoat anything because, quite frankly, the food industry already does enough of that already. You might not have ...
Soon after Borzelleca's paper was published in a scientific journal, Food and Chemical Toxicology, the FDA examined the data his team had collected and reached its own conclusion: that the dye caused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results